SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-070966
Filing Date
2024-06-07
Accepted
2024-06-07 18:36:33
Documents
1
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9349
  Complete submission text file 0000950170-24-070966.txt   10782
Mailing Address 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142
Business Address
Horobin Joanna (Reporting) CIK: 0001560959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 241031072

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)